Sandbox Reserved 1768
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
{{Template:CH462_Biochemistry_II_2023}}<!-- PLEASE ADD YOUR CONTENT BELOW HERE --> | {{Template:CH462_Biochemistry_II_2023}}<!-- PLEASE ADD YOUR CONTENT BELOW HERE --> | ||
- | == | + | ==Human Sodium Taurocholate Cotransporting Peptide== |
<StructureSection load='1stp' size='340' side='right' caption='Caption for this structure' scene=''> | <StructureSection load='1stp' size='340' side='right' caption='Caption for this structure' scene=''> | ||
- | + | ||
- | + | == Introduction == | |
+ | |||
== Function == | == Function == | ||
- | == Disease == | ||
- | == | + | === Bile Salt Uptake === |
+ | |||
+ | |||
+ | === HBV/HDV Infection === | ||
+ | |||
+ | |||
+ | == Structure == | ||
+ | |||
+ | |||
+ | === Proline/Glycine Hinge === | ||
+ | |||
+ | |||
+ | === Core and Panel Domains === | ||
+ | |||
+ | |||
+ | === Sodium Binding Region === | ||
- | == Structural highlights == | ||
=== Significant Residues === | === Significant Residues === | ||
<scene name='95/952696/Residues_84-87/1'>Residues 84-87</scene> of Human NTCP have been shown to be vital for preS1 recognition. | <scene name='95/952696/Residues_84-87/1'>Residues 84-87</scene> of Human NTCP have been shown to be vital for preS1 recognition. | ||
- | + | == Mechanisms == | |
+ | |||
+ | |||
+ | === Bile Salt Uptake === | ||
+ | |||
+ | |||
+ | === HBV/HDV Infection === | ||
+ | |||
+ | |||
+ | == Medical Relevance == | ||
+ | |||
</StructureSection> | </StructureSection> | ||
+ | |||
== References == | == References == | ||
+ | |||
+ | |||
<references/> | <references/> |
Revision as of 18:05, 13 March 2023
This Sandbox is Reserved from February 27 through August 31, 2023 for use in the course CH462 Biochemistry II taught by R. Jeremy Johnson at the Butler University, Indianapolis, USA. This reservation includes Sandbox Reserved 1765 through Sandbox Reserved 1795. |
To get started:
More help: Help:Editing |
Human Sodium Taurocholate Cotransporting Peptide
|